GHR Peptide-6 Side Effects: Safety Signals and Warnings
GHR Peptide-6 safety concerns are compound-specific. The main listed side effects are Limited safety data available, Possible local irritation at application site, and Potential appetite stimulation (shared with GHRP-6). The main warning signals are Not approved for clinical use in any country, Evidence base is limited and primarily from a single research group, and Relationship to GHRP-6 may carry similar endocrine side effects at systemic doses.
Direct Answer
Evidence for GHR Peptide-6 is too preliminary to support a research protocol with confidence. Published data is extremely limited, with no independent replication and no clinical trials. Of the Healing & Recovery compounds in this library, BPC-157 or thymosin beta-4 have substantially more preclinical evidence as starting points.
- Evidence grade
- Level D
- Research status
- Preclinical
- Category
- Healing & Recovery
- Best for
- No validated application at this stage
Reported Side Effects
- Limited safety data available
- Possible local irritation at application site
- Potential appetite stimulation (shared with GHRP-6)
- Theoretical cortisol and prolactin elevation
Warnings
- Not approved for clinical use in any country
- Evidence base is limited and primarily from a single research group
- Relationship to GHRP-6 may carry similar endocrine side effects at systemic doses
- Long-term safety profile is unknown
Known or Plausible Interactions
- Growth hormone releasing peptides (potential additive GH-releasing effects)
- Topical wound care agents (compatibility not established)
- Insulin (wound healing doses may affect blood glucose via GH pathway)
Regulatory Context
GHR Peptide-6 wound healing variant is a research compound. Not approved for clinical use. GHRP-6 and its analogs are classified as research chemicals in most jurisdictions and are banned by WADA.
Evidence Snapshot
| Evidence grade | Level D |
|---|---|
| Research status | Preclinical |
| Best supported outcomes | Chronic Wound Healing (Level D) and Burn Injury Recovery (Level D) |
| Primary citation count | 2 |
| Last reviewed | 2026-06-02 |
Related Guides
How to Cite This Page
ExaminePeptides. "GHR Peptide-6 Side Effects: Safety Signals and Warnings." Last reviewed 2026-06-02. https://examinepeptides.com/answers/ghr-peptide-6-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.